for July 2019
Breaking news 📢📢
— Antibiotic Steward (@ABsteward) July 17, 2019
FDA Approves Merck’s RECARBRIO™ (imipenem, cilastatin, and relebactam) For the treatment of adults with cUTI and cIAI Where Limited or No Alternative Treatment Options Are Available. #IDTwitter @SIDPharm @accpinfdprn @IDstewardshiphttps://t.co/ICls3tSr5C
JUST RELEASED 🔥🔥🔥
— Antibiotic Steward (@ABsteward) July 1, 2019
ICYMI :Top 🆔 /Stewardship Journal Articles Released in June 2019. https://t.co/g8KSrwOcjV 📲
A monthly post by @IDstewardship & @ABsteward #IDTwitter #IDMedEd #IDDailyPearl #medtwitter #MedEd #FOAMed
If you find this helpful Please RT/❤️share w others. pic.twitter.com/uMuOBnQJS7
NEW 🔥 multinational retrospective study in CID.
— Antibiotic Steward (@ABsteward) July 19, 2019
Ceftazidime, carbapenems, or piperacillin-tazobactam as single definitive therapy for pseudomonas aeruginosa BSI.
#IDTwitter @LeonardLeibovi1 @jesusrbano @paul_mical @davidantibiotic @EveTacconelli https://t.co/jD1QR1OvXg pic.twitter.com/f76WbLbp8o
"Increasingly, the scientists who study emerging infectious diseases, crop survival, air pollution, sea level rise, and extreme heat all warn that past performance may no longer be indicative of future results." https://t.co/idqJqpEhFi
— WIRED Science (@WIREDScience) July 9, 2019
Antimicrobial stewardship programs (ASP) are essential for optimising antibiotic use. But what is the impact of ASPs on the entire healthcare system?
— Clinical Microbiology and Infection (@CMIJournal) July 22, 2019
Promisingly, PIRASOA program demonstrated a positive ecological result at the healthcare system level. https://t.co/cb6GXAu0Ph pic.twitter.com/2VHZJpagHB
To procalcitonin, or not to procalcitonin? 🤔
— Antibiotic Steward (@ABsteward) July 31, 2019
A NEW 🌟🌟 🌏review article in #IJAA
Hot topics on challenging areas with procalcitonin use in clinical practice, can it help antibiotic stewardship? @ischemo#IDTwitter #IDuptodate https://t.co/hOOtR4xVsh pic.twitter.com/gwT5px48uA
NEW🔥 @CMIJournal
— Antibiotic Steward (@ABsteward) July 5, 2019
The largest retrospective study including all pts on cefepime&TDM
Pts w presumed CFP neurotoxicity had a significantly lower renal function & TDM should be systematically performed, aiming at trough concentrations < 7.5 mg/L #IDTwitter https://t.co/UQtr1WHUeN pic.twitter.com/Ny38tiIP9i
Check out CMI's series on antimicrobial stewardship!
— Clinical Microbiology and Infection (@CMIJournal) July 10, 2019
More than 36 articles dedicated to the definition, determinants, best practices of antimicrobial stewardship. https://t.co/QkQ7FsPiU8 pic.twitter.com/x8UCxl1Mf4
New Annals study and editorial: shorter is better!
— Brad Spellberg (@BradSpellberg) July 8, 2019
Excess Antibiotic Use in Patients Hospitalized With Pneumonia | Ann Intern Med | ACP | https://t.co/aWYTLaYvGe;
Duration of Antibiotic Therapy: Shorter Is Better | Ann Intern Med | ACP | https://t.co/wDb0Ygoixk
Ticks can carry infectious agents such as bacteria, viruses, or parasites, which can cause illness. Watch #CDCGrandRounds encore session, 7/16 at 1pm ET, to learn about emerging issues related to ticks and tickborne disease. https://t.co/THBrvIHwR2 pic.twitter.com/Vwm6fGY7N8
— CDC (@CDCgov) July 12, 2019
Excited to share our systematic review on clinical decision support systems and #AntimicrobialStewardship! A @VCUHealth fellow project; full text available here: https://t.co/AabhM2a5gJ pic.twitter.com/bldmYZqDSV
— Mike Stevens (@Dr_Mike_Stevens) July 25, 2019
Happy to share the Antimicrobial Stewardship in Cancer Consortium's call to action. stewardship efforts must be expanded to patients with cancer and oncologists must be involved in these efforts: https://t.co/s7Tnp0mqS9@Willeeuhmm @PergamIC @liliabbo @FTverdek @JNCCN @SIDPharm
— Sam Aitken (@OncIDPharmd) July 19, 2019
NEW🔥🔥 in JPP
— Antibiotic Steward (@ABsteward) July 22, 2019
Significant Publications on Infectious Diseases Pharmacotherapy in 2018.
✨✨@MerinoTrial top ID article
#IDTwitter cc @ShorterSeddonRx
Please Add more authors twitter handles https://t.co/ZI6CcFfHlM pic.twitter.com/ACF3lu4He2
NEW 🔥in @JACCPJournal @ErinMcCreary @BBookstaver_USC @theashleys @Warren_E_Rose
— Antibiotic Steward (@ABsteward) July 24, 2019
Designing Antimicrobial Stewardship Initiatives to Enhance Scientific Dissemination - via @blandman19 #IDTwitter https://t.co/gTxmulYVFh pic.twitter.com/B6hyGYEXvu
FDA approves IMI-REL (imipenem-relebactam), I mean “Recarbio”, a drug with activity against CRE and carbapenem-R Pseudomonas (CRPs), including IMI-R strains.
— Jason Gallagher (@JGPharmD) July 17, 2019
So, we have:
TOL-TAZ: CRE-, CRPs+
CAZ-AVI: CRE+, CRPs+
MER-VAB: CRE+, CRPs-
IMI-REL: CRE+, CRPs+https://t.co/dWffA8rqTC
Happy Friday! New RRT dosing review: Antibiotic Dosing for Critically Ill Adult Patients Receiving Intermittent Hemodialysis, Prolonged Intermittent Renal Replacement Therapy, and Continuous Renal Replacement Therapy: An Update https://t.co/GT9rDw1fQS
— SIDP (@SIDPharm) July 26, 2019
🔥🔥🔥 New (with great tables) - Antibiotic Dosing for Critically Ill Adult Patients Receiving Intermittent Hemodialysis, Prolonged Intermittent Renal Replacement Therapy, and Continuous Renal Replacement Therapy: An Update https://t.co/GwSiBHrd5W
— ACCP INFD PRN (@accpinfdprn) July 26, 2019
National analgesic advice sheet for dentists has been published and added to the Dental Antimicrobial Stewardship toolkit #AntibioticsDontCureToothache cc @DentalPHE @Dammo @SMHopkins @Susie_Sanderson @wendythedentist https://t.co/BPDLQEIFTW #dentists pic.twitter.com/UoUyikXRp4
— Diane Ashiru, PhD (@DrDianeAshiru) July 29, 2019
Day #12. In a low TB prevalence setting (USA), a single negative Xpert MTB/RIF sputum test had a negative predictive value for TB of 99.7%; two tests 100%! This study has had a major impact on infection control policies in US hospitals. @ACTGNetwork https://t.co/cqNZFMn58B
— Paul Sax (@PaulSaxMD) July 7, 2019
NEW🔥 in #JACnews
— Antibiotic Steward (@ABsteward) July 13, 2019
Emotional, cognitive and social factors of antimicrobial prescribing: can antimicrobial stewardship intervention be effective without addressing psycho-social factors?#IDTwitter https://t.co/clB5DiCsX5 pic.twitter.com/iFCErM43rz
📄 New in @ICHEJournal via @SHEA_Epi on #ASB, a hugely important topic for #abxstewardship #IDtwitter
— Bug Pharmacist 💊🦠 Tim Gauthier (@IDstewardship) July 25, 2019
📲 https://t.co/XJydaDWFw2
PI @bwtrautner with support from @glavaidguy @Payal_Patel @Ddrekonja and I! Can’t say enough about the 🥾Kicking UTI Team!!!! pic.twitter.com/gjwwMtxfKa
Gut microbiota and colonization resistance against bacterial enteric infection: a #MMBRJournal review https://t.co/Eu0mA5xaVg pic.twitter.com/8DLZzf5QHB
— ASM (@ASMicrobiology) July 19, 2019
'Antibiotic resistance is an increasingly serious threat to public health. This article discusses the concept of the "antibiotic footprint" as a tool to communicate the magnitude of antibiotic use in humans, animals & industry' #JACNews #OpenAccess https://t.co/eqZ1iN2hO0
— BSAC (@BSACandJAC) July 29, 2019
Just Published 🔥 🔥 in #IJAA by our @SIDPharm Dr. Avery @IDpharmresearch @OncIDPharmd @nbritt_pharmd
— Antibiotic Steward (@ABsteward) July 6, 2019
Pharmacodynamics of daptomycin when prescribed in combination with other antibiotics for treatment of enterococcal bacteremia. #IDTwitter #IDuptodate, https://t.co/IK0pvOyaSU pic.twitter.com/v0p9KnacDy
News from #AAIC19: Discussion to take place on the role of infectious agents in Alzheimer’s. “There is now growing evidence that microbes such as bacteria and viruses may play a role in degenerative brain diseases, such as Alzheimer’s.” @DrMariaALZ https://t.co/SAa6BKXxl2 #ENDALZ pic.twitter.com/7RPaEUTWBM
— Alzheimer's Assoc. (@alzassociation) July 16, 2019
Is #HIV a curable disease? A new study suggests yes, as researchers find success in eliminating the disease from an infected animal’s genome through a combo of modified ARV treatment & gene-editing tool CRISPR-cas9. https://t.co/hrqZc4hATU #EndHIVEpidemic
— IDSA (@IDSAInfo) July 3, 2019
New online: Long-term all-cause mortality in people treated for tuberculosis: a systematic review and meta-analysis https://t.co/AHjfK73NNX
— The Lancet Infectious Diseases (@TheLancetInfDis) July 17, 2019
Interesting that antibiotic-resistant E. coli survived >70 days on dry surfaces in this lab study; longer than you might expect! @aricjournal https://t.co/Z8BH8Wf03x #aricjournal
— Jon Otter (@jonotter) July 1, 2019
Just dropped! A new #SIDPbreakpoints podcast miniseries on leadership & advocacy in #antimicrobialstewardship. @LisaIDpharmD @theashleys @KisgenUF & host @ErinMcCreary cover essentials for new and seasoned antimicrobial stewards alike! https://t.co/ay99lPym65 pic.twitter.com/s0umBwWSOW
— SIDP (@SIDPharm) July 31, 2019
Very interesting!🔥
— Antibiotic Steward (@ABsteward) July 2, 2019
A new experimental 🇫🇷 study in #JACnews suggested that the combination of colistin and tigecycline should be administered with caution, as it may be antagonistic in vitro and in vivo.#IDTwitter https://t.co/8x6O6HRrYH pic.twitter.com/ZJQo7fhbEw
ICYMI A Propensity Score–Adjusted Analysis 🔥 @jesusrbano OFID Echinocandin therapy in the first 48 hours compared with azoles,seems not to improve the outcome of non–ICU patients with septic shock due to candidemia. #IDTwitter https://t.co/oplc2NYDmz pic.twitter.com/HB2IrAgtxg
— Antibiotic Steward (@ABsteward) July 16, 2019
As for the answer...
— Bug Pharmacist 💊🦠 (@IDstewardship) July 11, 2019
I remember it as once MSSA goes to “mecca” (sounds like MecA), it becomes MRSA.
🤓 Here is a table from my antibiotic resistance cheat sheet at https://t.co/SZYFCKcBRF providing info on some important resistance genes... pic.twitter.com/fVb0SRypXn
This new article on antibiotic dosing in CRRT is a much needed update to the older review articles out there. And that comprehensive table that includes the molecular weights and free fractions for so many antibiotics?? Swooning. 🥰https://t.co/2uWMWaQU8O
— Emily Heil (@emilylheil) July 26, 2019
Drug-resistant superbug spreading in Europe's hospitals.
— Microbes&Infection (@MicrobesInfect) July 30, 2019
This is the largest study of #carbapenem resistance in #Klebsiella pneumoniae, with 244 hospitals involved from Ireland to Israel. https://t.co/IeaeR1MbSN #AntibioticResistance pic.twitter.com/oqS2d3jsHX
SHEA Research Network data suggest antibiotic stewardship may play a key role during end-of-life care. Stewardship collaborations with palliative care may promote patient-centered goals of care. #SHEAResearch #antimicrobialstewardship
— ICHE Journal (@ICHEJournal) July 22, 2019
Full article: https://t.co/orjMIxzptR pic.twitter.com/BsjkTl6d89
Excited to see our @serge_45_ABX group discussed. Designing Antimicrobial Stewardship Initiatives to Enhance Scientific Dissemination - Pagels - - JACCP: JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACY - Wiley Online Library https://t.co/IuEe2nILT2
— Chris Bland (@blandman19) July 24, 2019
Homelessness at diagnosis is associated with death among people with HIV in a population-based study of a U.S. City. - being homeless at time of HIV Dx increases your risk of death 27-fold. Housing is healthcare! @drmt @Armstrws https://t.co/VwYq7aj1LX
— Carlos del Rio (@CarlosdelRio7) July 8, 2019
If the profitability of #antimicrobials is tied to their sales, then antimicrobial stewardship & efforts to minimise use of these vital medicines will be undermined. We need vaccines as well thinking outside the box. Great piece by @HarvardChanDean: https://t.co/DmyfXBzPqf
— Seth Berkley (@GaviSeth) July 10, 2019
NEW 🔥 retrospective study in Annals of Pharmacotherapy @MLPharm
— Antibiotic Steward (@ABsteward) July 19, 2019
The 2016 FDA boxed warning was NOT significantly associated with ⬇️ FQ prescribing for uncomplicated UTI across a large academic family med practice#IDTwitter#stop_fluoroquinolones_madness https://t.co/gLfpwmkiCQ pic.twitter.com/d3lkMClSfg
NEW 🔥 @jesusrbano @CMIJournal
— Antibiotic Steward (@ABsteward) July 16, 2019
Outcomes of the PIRASOA 🇪🇸 ASP
⚡Optimising the use of antimicrobial agents
⬇️ Total antimicrobial consumption esp Amoxi. Clav, penems, FQs
⬇️ incidence of MDR
The mortality of patients with BSI remained stable #IDTwitter https://t.co/9jdm7GQs0P pic.twitter.com/GiN1dMRGxz
NEW ✨ @JACCPJournal @DrDrayMBA @Ben_Heikkinen @MeganARech Pharmacists' Perceptions and Practice Changes Resulting from Emergence of the Vancomycin‐Piperacillin/Tazobactam Nephrotoxicity Phenomenon. #IDTwitter https://t.co/PMTO6bWpqL pic.twitter.com/j7BT5I7yZn
— Antibiotic Steward (@ABsteward) July 29, 2019
Very Interesting!
— Antibiotic Steward (@ABsteward) July 2, 2019
NEW🔥 CID @pillsandskills @TimbrookTT @EmilySpivak
Penicillin as a Potential Agent for Dual Beta-lactam Therapy for Enterococcal Endocarditis
PCN presents an attractive option based on feasibility of outpatient administration. #IDTwitter https://t.co/0ufPAMSj1n pic.twitter.com/XbtD7xhPqZ
Should stewardship programs be engaging behavior experts? New in @BSACandJAC https://t.co/yUXHg1EUt3
— Bug Pharmacist 💊🦠 (@IDstewardship) July 18, 2019
I think yes if you can, but full time I am not sure. pic.twitter.com/dGg58Ngmwy
"Increasingly, the scientists who study emerging infectious diseases, crop survival, air pollution, sea level rise, and extreme heat all warn that past performance may no longer be indicative of future results." https://t.co/DcwN42wooq
— Caitlin Kelly (@caitlin__kelly) July 8, 2019
'In the race to prevent antimicrobial resistance the world has a potent if underused tool: vaccines'
— AMR at Wellcome (@Wellcome_AMR) July 3, 2019
Want to know why vaccines must be a central part of our response to drug-resistant infections? Read what @JeremyFarrar and @GaviSeth said to @ProSyn 👇https://t.co/0K6F4fs8pC
'Antimicrobial stewardship—a practical guide to implementation in hospitals' JAC-Antimicrobial Resistance (JAC-AMR), Volume 1, Issue 1, June 2019 #JACAMRnews https://t.co/388cgTGq3s
— Antibiotic Action (@TheUrgentNeed) July 16, 2019
Phylogenetic analysis to compare the temperature susceptibility of C. auris with those of its close relatives suggest that it may be the first example of a new fungal disease emerging from climate change @mbiojournal https://t.co/gOiHMmxuyY pic.twitter.com/0xkEyJJoG6
— ASM (@ASMicrobiology) July 26, 2019
#Recarbrio was FDA approved! Here are my cliff notes and links to relevant readingshttps://t.co/j8DYVpVBkl#IDtwitter #Antibiotic #Pharmacist
— Bug Pharmacist 💊🦠 (@IDstewardship) July 18, 2019
Anything you would add? pic.twitter.com/DFeXCtdLQ6
A NEW ✨✨ RCT in CID
— Antibiotic Steward (@ABsteward) July 27, 2019
Effect of oral oseltamivir on virological outcomes in low-risk adults with influenza.
Oseltamivir ⬇️ viral shedding in this low-risk population. But, it did not significantly ⬇️ the time to resolution of clinical symptoms. #IDTwitter https://t.co/qdqy8wqBwI pic.twitter.com/yegU8tZiAT
🔥 New article alert!!
— Bug Pharmacist 💊🦠 (@IDstewardship) July 19, 2019
I asked what it’s all about and they laid it out. I found learning about their work to be 🤩 inspiring, perhaps you will too!
Like #abxstewardship? Learn here about @CIDRAP and @CIDRAP_ASP https://t.co/QYhhKh2iSN #IDtwitter #SaveABX w/ @natalievestin pic.twitter.com/utmnf6beOx
WashU infectious diseases expert Caline Mattar, MD, has been appointed a chair of the Expert Advisory Group for the Global Antimicrobial Resistance R&D Hub, where she will evaluate antibiotics aimed at combating TB and other pathogens. https://t.co/tJuKgkwLJE
— Washington U. Med (@WUSTLmed) July 23, 2019
Created by Cameron Forbes. Last updated November 10, 2019 at 15:41 EST.